Metabolic Health Risk in South Asian Populations

Share this

Metabolic Health Risk in South Asian Populations

Position Statement on Metabolic Health Risk in South Asian Populations

This statement provides evidence-informed guidance for healthcare practitioners regarding the recognition, screening, and lifestyle-based management of elevated metabolic health risk in South Asian populations.

Position Statement

Summary

AMHS recognises that South Asian populations experience increased metabolic risk at younger ages and lower BMI thresholds than White European populations.
Current evidence supports earlier metabolic screening, consideration of lower anthropometric thresholds, and culturally tailored lifestyle interventions in this population. (3-9)
AMHS supports lifestyle-first approaches that prioritise dietary quality, reduction in refined carbohydrate intake, preservation of skeletal muscle mass, physical activity, adequate protein intake, sleep optimisation, and reduction in ultra-processed food consumption. (10-15)


PART 1: EXECUTIVE SUMMARY

Australasian Metabolic Health Society (AMHS)

Position Statement on Metabolic Health Risk in South Asian Populations

Position Statement Number: PS-02/2026
Issue Date: 14 August 2026
Review Date: 14 August 2029
Approved by: AMHS Scientific Committee
Date of Approval: 14 August 2026


PURPOSE OF THIS STATEMENT

This statement provides evidence-informed guidance for healthcare practitioners regarding the recognition, screening, and lifestyle-based management of elevated metabolic health risk in South Asian populations.

South Asians experience disproportionately high rates of insulin resistance, type 2 diabetes, cardiovascular disease, and metabolic dysfunction at younger ages and lower BMI thresholds than many other ethnic groups. (1-3)


SCOPE

Target Audience

  • General practitioners
  • Endocrinologists
  • Cardiologists
  • Dietitians
  • Diabetes educators
  • Lifestyle medicine practitioners
  • Nurses and allied health professionals
  • Researchers and policymakers

Applies To

Adult South Asian populations, including individuals originating from India, Pakistan, Bangladesh, Sri Lanka, Nepal, Bhutan, and the Maldives, including diaspora populations living in Australia.

Does NOT Apply To

  • Type 1 diabetes management
  • Paediatric metabolic disease
  • Pregnancy-specific treatment protocols
  • Pharmacological treatment algorithms

AMHS POSITION

AMHS recognises that South Asian populations experience increased metabolic risk at younger ages and lower BMI thresholds than White European populations.

Current evidence supports earlier metabolic screening, consideration of lower anthropometric thresholds, and culturally tailored lifestyle interventions in this population. (3-9)

AMHS supports lifestyle-first approaches that prioritise dietary quality, reduction in refined carbohydrate intake, preservation of skeletal muscle mass, physical activity, adequate protein intake, sleep optimisation, and reduction in ultra-processed food consumption. (10-15)


KEY RECOMMENDATIONS

1. Earlier Metabolic Screening

Recommendation: Consider earlier metabolic screening in South Asian adults from age 25–35 years, or earlier in the presence of additional risk factors.
Rationale: South Asians frequently develop insulin resistance and type 2 diabetes at younger ages and lower BMI thresholds. (1, 3, 8)

2. Lower Anthropometric Thresholds

Recommendation: Consider lower BMI and waist circumference thresholds when assessing metabolic risk in South Asian populations (see Appendix A for recommended screening thresholds).
Rationale: Equivalent metabolic risk occurs at lower BMI levels in South Asians compared with White European populations. (3, 5)

3. Dietary Quality and Refined Carbohydrate Reduction

Recommendation: Encourage reduction in refined carbohydrates and ultra-processed foods while supporting culturally appropriate whole-food dietary patterns.
Rationale: High intake of refined carbohydrates is associated with increased metabolic risk and incident type 2 diabetes. (10)

4. Muscle Preservation and Physical Activity

Recommendation: Encourage resistance exercise, regular physical activity, and adequate protein intake to support skeletal muscle preservation and insulin sensitivity.
Rationale: Reduced skeletal muscle mass and increased visceral adiposity contribute to metabolic dysfunction in South Asians.(11-14) 

5. Culturally Tailored and Family-Centred Care

Recommendation: Provide culturally responsive and family-aware lifestyle interventions.
Rationale: Cultural identity, family structure, and food traditions strongly influence dietary behaviours and long-term adherence. (16)


SUMMARY

South Asian populations experience increased susceptibility to metabolic disease at younger ages and lower BMI thresholds than many other ethnic groups.

Current evidence supports earlier screening, lower anthropometric thresholds, and culturally tailored lifestyle interventions in this population.

AMHS supports lifestyle-first approaches that prioritise dietary quality, skeletal muscle preservation, physical activity, and reduction in ultra-processed food intake.


WRITING COMMITTEE

  • Dr Nelum Dharmapriya MBChB, MRCP, FRACGP 
  • [Additional AMHS Scientific Committee Members Pending]

CONFLICTS OF INTEREST

All writing committee members have declared potential conflicts of interest in accordance with AMHS policy. Details are available in the supporting document.


FOR MORE INFORMATION

The full supporting document with detailed evidence review and references is available via the Australasian Metabolic Health Society.


HOW TO CITE THIS STATEMENT

Australasian Metabolic Health Society Scientific Committee. AMHS Position Statement on Metabolic Health Risk in South Asian Populations. AMHS Position Statement PS-XX/2026. [Month 2026].



PART 2: SUPPORTING DOCUMENT

AMHS POSITION STATEMENT SUPPORTING DOCUMENT

Metabolic Health Risk in South Asian Populations


1. COVER PAGE

Statement Number: PS-XX/2026
Full Title: AMHS Position Statement on Metabolic Health Risk in South Asian Populations
Issue Date: [Month 2026]
Review Date: [Month 2029]
Status: Draft


2. WRITING COMMITTEE MEMBERS

Members

Dr Nelum Dharmapriya MBChB, MRCP, FRACGP

  • GP, Narangba Doctors, Brisbane, Queensland
  • Whole Food Revolution | Brisbane, Australia
  • Role in statement development: Lead author and primary evidence synthesis
  • Conflicts of interest: None declared

Additional AMHS Scientific Committee Members

  • Pending committee review and approval

3. BACKGROUND AND CONTEXT

South Asians represent nearly one-quarter of the global population and one of the fastest-growing migrant populations in Australia. Epidemiological studies consistently demonstrate that South Asians develop type 2 diabetes, cardiovascular disease, hypertension, and metabolic dysfunction at younger ages and lower BMI thresholds than White European populations. (1-3, 17)

Large cohort studies including CARRS and UK-based South Asian cohort studies have demonstrated increased insulin resistance, greater visceral adiposity, reduced beta-cell reserve, and earlier cardiometabolic disease progression in South Asian populations. (1, 2, 17)

Australian data confirm this is also relevant locally. Recent analysis of National Diabetes Services Scheme (NDSS) data demonstrated continuing increases in diabetes incidence among some Asian-born groups, including South Asian men, despite stabilisation or decline in some Australian-born populations. (18)

South Asians frequently demonstrate a metabolic phenotype characterised by increased visceral adiposity, reduced skeletal muscle mass, insulin resistance, and metabolic dysfunction at lower BMI levels. (3, 5, 10, 11) 

Migration-related dietary transition, physical inactivity, sedentary behaviour, sleep disruption, and increased intake of refined carbohydrates and ultra-processed foods may further amplify risk. (10-15, 17)

AMHS considers this an important area for metabolic health guidance because current Australian screening and prevention approaches may underestimate risk in South Asian populations.


4. SCOPE AND DEFINITIONS

4.1 Scope

This position statement addresses:

  • Metabolic health risk in adult South Asian populations
  • Earlier screening approaches
  • Lifestyle-based prevention and management strategies
  • Culturally tailored metabolic health interventions

This position statement does NOT address:

  • Pharmacological management algorithms
  • Type 1 diabetes
  • Paediatric populations
  • Pregnancy-specific metabolic protocols

4.2 Key Definitions

South Asian Populations

Individuals originating from India, Pakistan, Bangladesh, Sri Lanka, Nepal, Bhutan, and the Maldives.

Therapeutic Carbohydrate Reduction

A dietary approach involving reduction in refined and high-glycaemic carbohydrate intake to improve metabolic health markers.

Time-Restricted Eating (TRE)

A dietary timing strategy restricting food intake to a defined daily eating window.

Metabolic Dysfunction

A constellation of metabolic abnormalities including insulin resistance, dysglycaemia, visceral adiposity, dyslipidaemia, hypertension, and MASLD.

MASLD

Metabolic dysfunction-associated steatotic liver disease.


5. ABBREVIATIONS

AbbreviationDefinition
AMHSAustralasian Metabolic Health Society
BMIBody Mass Index
CVDCardiovascular Disease
MASLDMetabolic dysfunction-associated steatotic liver disease
TRETime-Restricted Eating
T2DType 2 Diabetes
NDSSNational Diabetes Services Scheme
ADAAmerican Diabetes Association
NICENational Institute for Health and Care Excellence

6. METHODOLOGY

6.1 Literature Search

Literature searches were conducted using PubMed and Google Scholar for English-language publications relevant to South Asian metabolic health, screening thresholds, lifestyle interventions, insulin resistance, physical activity, and dietary approaches.

Key search terms included:

  • South Asian diabetes
  • South Asian insulin resistance
  • South Asian metabolic syndrome
  • South Asian BMI thresholds
  • resistance training diabetes South Asians
  • time-restricted eating insulin sensitivity
  • South Asian cardiovascular risk

Priority was given to:

  • Systematic reviews
  • Randomised controlled trials
  • Cohort studies
  • Guideline statements
  • Position statements from recognised medical organisations

6.2 Evidence Selection

Included evidence comprised:

  • Randomised controlled trials
  • Large cohort studies
  • Systematic reviews
  • Meta-analyses
  • Major guideline statements
  • South Asian-specific epidemiological studies

Case reports and non-peer-reviewed opinion articles were excluded unless highly relevant to implementation or cultural context.

6.3 Evidence Review Process

Evidence was reviewed and synthesised according to relevance to South Asian metabolic health risk and applicability to Australian clinical practice.

Preference was given to:

  • South Asian-specific data
  • High-quality metabolic and cardiovascular outcomes studies
  • Australian and international guideline-level evidence

6.4 Consensus Process

Recommendations were drafted based on review of current evidence and refined to align with AMHS principles of evidence-informed, lifestyle-first metabolic healthcare.

Recommendations are intended to support clinical judgement rather than replace individualised care.


6.5 EVIDENCE GRADING APPROACH

Recommendations within this statement were informed by:

  • Quality and consistency of available evidence
  • Applicability to South Asian populations
  • Relevance to Australian clinical practice
  • Balance of benefits and potential harms
  • Clinical feasibility and implementation considerations

Because South Asian-specific interventional data remain limited in some areas, several recommendations incorporate expert consensus informed by broader metabolic health evidence.

Interpretation of Strength of Evidence

StrengthInterpretation
StrongConsistent evidence from multiple cohort studies, systematic reviews, or guideline-level evidence
ModerateSupportive evidence exists, but South Asian-specific data may be limited
EmergingEarly or mechanistic evidence supports potential benefit, but long-term or population-specific data remain limited

7. EVIDENCE REVIEW

7.1 Earlier Metabolic Risk in South Asians

Background

South Asians experience disproportionately high rates of type 2 diabetes and cardiovascular disease at younger ages and lower BMI thresholds than White European populations. (1, 2, 19)

What the Evidence Shows

The CARRS cohort demonstrated substantial cardiometabolic burden across South Asian populations. (1)

UK-based South Asian cohort studies demonstrate increased coronary artery disease risk independent of BMI and cholesterol. (2, 17, 19)

Large epidemiological studies also demonstrate more rapid progression from prediabetes to diabetes in South Asian populations. (20)

Summary and Implications

Current evidence supports consideration of earlier metabolic screening and lower anthropometric thresholds in South Asian populations. (3-9)


7.2 The South Asian Metabolic Phenotype

Background

South Asians frequently demonstrate a metabolic phenotype characterised by increased visceral adiposity, reduced skeletal muscle mass, insulin resistance, and metabolic dysfunction at lower BMI levels. (3, 5, 11)

What the Evidence Shows

Studies demonstrate greater metabolic risk at BMI levels considered normal in White European populations. (3, 5)

Ethnicity-specific BMI threshold studies support lower intervention thresholds in South Asians. (3, 5)

Summary and Implications

BMI alone may underestimate metabolic risk in South Asian populations. (3, 5)


7.3 Dietary Quality and Refined Carbohydrate Intake

Background

Dietary transition following migration and urbanisation has altered traditional South Asian eating patterns. (10, 11, 17)

What the Evidence Shows

High intake of polished white rice and refined carbohydrates is associated with increased diabetes risk. (10)

Summary and Implications

Reduction in refined carbohydrates and ultra-processed foods may improve metabolic health markers. (10) 


7.4 Physical Activity and Muscle Preservation

Background

Reduced skeletal muscle mass contributes to insulin resistance and impaired glucose disposal. (11-14)

What the Evidence Shows

Resistance exercise and higher-intensity physical activity improve insulin sensitivity and glycaemic control in South Asian populations. (13, 14)

Summary and Implications

Muscle-focused exercise should form part of metabolic risk reduction strategies.(13, 14)


7.5 Time-Restricted Eating

Background

Time-restricted eating has emerged as a potential metabolic intervention. (15)

What the Evidence Shows

Controlled trials demonstrate improvements in insulin sensitivity and metabolic markers independent of weight loss. (15)

South Asian-specific intervention data remain limited.

Summary and Implications

TRE may be considered as part of individualised lifestyle interventions where clinically appropriate. (15)


7.6 Family and Cultural Influences

Background

Family structure and cultural food practices strongly influence lifestyle behaviours in South Asian communities. (16) 

What the Evidence Shows

Evidence from the MASALA study suggests adult children influence parental health behaviours and engagement with preventive care.(16)  

Summary and Implications

Culturally tailored and family-aware interventions may improve long-term adherence. (16)   1


8. POSITION STATEMENT PRINCIPLES

This statement is guided by the following AMHS principles:

  • Recognition of metabolic heterogeneity across ethnic groups
  • Prioritisation of lifestyle-first metabolic healthcare
  • Evidence-informed and culturally responsive clinical care
  • Shared decision-making between clinicians and patients
  • Emphasis on prevention and early intervention

This statement is intended to support—not replace—clinical judgement and individualised patient care.


9. EVIDENCE GAPS AND LIMITATIONS

9.1 Gaps in Current Evidence

  • Limited South Asian-specific randomised controlled trials
  • Underrepresentation of women in metabolic studies
  • Limited Australian South Asian cohort data
  • Limited long-term data regarding TRE and carbohydrate reduction in South Asians
  • Variable representation across different South Asian ethnic groups

9.2 Limitations of This Review

This review relied primarily on English-language publications and did not perform formal meta-analysis.

Some recommendations are informed by emerging evidence and expert consensus, where South Asian-specific intervention data remain limited.

9.3 Research Priorities

  • Australian South Asian metabolic cohort studies
  • Women-focused metabolic research
  • Long-term lifestyle intervention trials
  • Community-based prevention strategies
  • Ethnicity-specific cardiovascular risk assessment tools

10. RATIONALE FOR RECOMMENDATIONS

Recommendation 1: Earlier Metabolic Screening

Evidence Supporting This Recommendation

South Asians demonstrate an earlier onset of type 2 diabetes and cardiovascular disease.

Strength of Evidence

Moderate to strong.

Practical Considerations

Earlier screening may improve early identification and intervention.

Potential Harms/Risks

Potential over-screening must be balanced against high metabolic risk.

Balance of Benefits vs Risks

Benefits likely outweigh risks in high-risk populations.


Recommendation 2: Lower Anthropometric Thresholds

Evidence Supporting This Recommendation

Equivalent metabolic risk occurs at lower BMI thresholds in South Asians.

Strength of Evidence

Strong.

Practical Considerations

Clinicians should interpret BMI within ethnic context.

Potential Harms/Risks

Potential for confusion if inconsistent with standard BMI categories.

Balance of Benefits vs Risks

Benefits outweigh risks.


Recommendation 3: Reduction in Refined Carbohydrates

Evidence Supporting This Recommendation

High refined carbohydrate intake is associated with increased diabetes risk.

Strength of Evidence

Moderate.

Practical Considerations

Interventions should remain culturally appropriate.

Potential Harms/Risks

Overly restrictive advice may reduce adherence.

Balance of Benefits vs Risks

Benefits likely outweigh risks when individualised.


Recommendation 4: Muscle Preservation and Exercise

Evidence Supporting This Recommendation

Resistance exercise improves insulin sensitivity and metabolic markers.

Strength of Evidence

Moderate.

Practical Considerations

Programs should be individualised.

Potential Harms/Risks

Exercise-related injury risk should be considered.

Balance of Benefits vs Risks

Benefits outweigh risks.


Recommendation 5: Culturally Tailored Care

Evidence Supporting This Recommendation

Culturally adapted interventions improve engagement and sustainability.

Strength of Evidence

Moderate.

Practical Considerations

Advice should respect cultural food practices.

Potential Harms/Risks

Minimal.

Balance of Benefits vs Risks

Benefits strongly outweigh risks.


11. IMPLEMENTATION CONSIDERATIONS

11.1 For Healthcare Practitioners

  • Consider earlier screening in South Asian adults
  • Use lower BMI and waist circumference thresholds
  • Encourage culturally appropriate lifestyle interventions
  • Prioritise skeletal muscle preservation and physical activity

11.2 For Patients

  • Metabolic risk may occur at a lower body weight
  • Small sustainable changes may improve metabolic health
  • Traditional foods can often be modified rather than eliminated

11.3 For Healthcare Systems

  • Improve culturally tailored metabolic health resources
  • Increase awareness of South Asian metabolic risk
  • Support earlier screening initiatives

11.4 Resources Needed

  • Clinician education
  • Community-based resources
  • Culturally appropriate dietary education materials
  • Further South Asian-specific research

12. RELATION TO OTHER GUIDANCE

12.1 Alignment with Existing Guidelines

This statement aligns with:

  • ADA recognition of lower BMI thresholds in Asian populations
  • WHO recommendations regarding Asian BMI thresholds
  • NICE guidance regarding diabetes prevention in high-risk groups
  • Australian cardiovascular risk assessment principles

12.2 Differences from Existing Guidelines

This statement places greater emphasis on:

  • South Asian-specific metabolic vulnerability
  • Skeletal muscle preservation
  • Family-centred care
  • Culturally tailored interventions

12.3 Complementary Guidance

This statement is intended to complement, not replace:

  • Australian diabetes guidelines
  • Australian cardiovascular disease risk guidelines
  • Existing metabolic health guidance

13. REVIEW AND UPDATE PROCESS

This position statement will be reviewed in 2029 or earlier if:

  • Significant new evidence emerges
  • Major guideline changes occur
  • Safety concerns are identified
  • Requested by the AMHS Scientific Committee

14. APPENDICES

Appendix A: Suggested Screening Thresholds for South Asian Adults

MeasureSuggested Threshold
BMI – Overweight≥23 kg/m²
BMI – Obesity≥27 kg/m²
Waist circumference (men)≥90 cm
Waist circumference (women)≥80 cm
Waist-to-height ratio≥0.5

Appendix B: Practical Lifestyle Strategies

  • Reduce refined carbohydrates
  • Increase minimally processed foods
  • Prioritise adequate protein intake
  • Encourage resistance exercise
  • Reduce sedentary behaviour
  • Encourage culturally sustainable lifestyle change

Appendix C: Suggested Areas for Future Research

  • South Asian-specific randomised controlled trials
  • Australian South Asian cohort studies
  • Women-focused metabolic health research
  • Long-term studies of therapeutic carbohydrate reduction
  • Time-restricted eating interventions in South Asian populations
  • Community-based and family-centred prevention models
  • Ethnicity-specific cardiovascular risk prediction tools

15. ACKNOWLEDGEMENTS

The authors acknowledge the contribution of South Asian clinicians, researchers, patients, and communities whose work and lived experience continue to inform metabolic health advocacy and research.


16. DISCLAIMER

This position statement is intended for educational and informational purposes only. It does not replace individualised medical advice, clinical judgement, or existing national clinical guidelines. Recommendations should be interpreted within the context of individual patient circumstances and evolving evidence.


17. FINAL REFERENCE NOTE

This document uses Vancouver referencing style throughout. All references were reviewed for consistency with publicly indexed journal and guideline records at the time of manuscript preparation.


18. REFERENCES

1. Kondal D, Patel S, Ali M, Deepa M, Rautela G, Gujral U, et al. Cohort Profile: The Center for cArdiometabolic Risk Reduction in South Asia (CARRS). International Journal of Epidemiology. 2022;51:e358-e71.

2. Tan ST, Scott W, Panoulas V, Sehmi J, Zhang W, Scott J, et al. Coronary heart disease in Indian Asians. Global Cardiology Science and Practice. 2014;2014(1):13-23.

3. Caleyachetty R, Barber TM, Mohammed NI, Cappuccio FP, Hardy R, Mathur R, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. The Lancet Diabetes & Endocrinology. 2021;9(7):419-26.

4. Force UPST. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;326(8):736-43.

5. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-63.

6. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20-s42.

7. National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk (PH38). 2012 (updated 2017).

8. Diabetes UK. Risk of Type 2 diabetes in the South Asian community 2023 [Available from: https://www.diabetes.org.uk/node/12895.

9. Nelson MR, Banks E, Brown A, Chow CK, Peiris DP, Stocks NP, et al. 2023 Australian guideline for assessing and managing cardiovascular disease risk. Med J Aust. 2024;220(9):482-90.

10. Bhavadharini B, Mohan V, Dehghan M, Rangarajan S, Swaminathan S, Rosengren A, et al. White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries. Diabetes Care. 2020;43:dc192335.

11. Misra A, Khurana L. Misra, A. & Khurana, L. Obesity and the metabolic syndrome in developing countries. J. Clin. Endocrinol. Metab. 93 (Suppl. 1), S9-S30. The Journal of clinical endocrinology and metabolism. 2008;93:S9-30.

12. Joint WHO/FAO/UNU Expert Consultation on Protein and Amino Acid Requirements in Human Nutrition. Protein and amino acid requirements in human nutrition. Geneva: World Health Organization; 2007.

13. Misra A, Alappan NK, Vikram NK, Goel K, Gupta N, Mittal K, et al. Effect of supervised progressive resistance-exercise training protocol on insulin sensitivity, glycemia, lipids, and body composition in Asian Indians with type 2 diabetes. Diabetes Care. 2008;31(7):1282-7.

14. Sargeant JA, Jelleyman C, Coull NA, Edwardson CL, Henson J, King JA, et al. Improvements in Glycemic Control After Acute Moderate-Intensity Continuous or High-Intensity Interval Exercise Are Greater in South Asians Than White Europeans With Nondiabetic Hyperglycemia: A Randomized Crossover Study. Diabetes Care. 2021;44(1):201-9.

15. Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metabolism. 2018;27(6):1212-21.e3.

16. Ram A, Dave SS, Lancki N, Moran M, Puri-Taneja A, Mammen S, et al. Social influence of adult children on parental health behavior among South Asian immigrants: findings from the MASALA (Mediators of Atherosclerosis in South Asians Living in America) study. Ethn Health. 2022;27(3):639-57.

17. Saeed S, Kanaya A, Bennet L, Nilsson P. Cardiovascular risk assessment in South and Middle-East Asians living in the Western countries. Pakistan Journal of Medical Sciences. 2020;36.

18. Magliano DJ, Chen L, Morton JI, Buyadaa O, Salim A, Shaw JE. Changes in the incidence of type 2 diabetes in Australia, 2005–2019, overall and by socio-demographic characteristics: a population-based study. Medical Journal of Australia. 2024;221(9):473-9.

19. Chaturvedi N. Ethnic differences in cardiovascular disease. Heart. 2003;89(6):681-6.

20. Gardner MP, Wang J, Hazlehurst JM, Sainsbury C, Blissett J, Nirantharakumar K, et al. Risk of progression from pre-diabetes to type 2 diabetes in a large UK adult cohort. Diabetic Medicine. 2023;40(3):e14996.